Last updated on November 2019
A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD) Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects
Brief description of study
"This is a single-center, randomized, double-blind, and placebo-controlled trial designed to:
- demonstrate the degree to which administered andexanet doses can reverse Factor Ten A (FXa)-inhibitor induced anticoagulation; and 2) evaluate the safety and PK/PD of andexanet in healthy Japanese subjects taking direct FXa inhibitors at therapeutic doses."
Clinical Study Identifier: NCT03310021